# Stallergenes Greer clinical trials: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with Stallergenes Greer as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Stallergenes Greer: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/stallergenes-greer

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 27, 2024 | NCT06574061 | Evaluation of the Benefits of Sublingual AIT (PRACTIS) | Stallergenes Greer | Observational | Completed | Allergic Rhinitis | 1,635 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06574061) |
| December 29, 2022 | NCT05668390 | Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma | Stallergenes Greer | Phase 3 | Completed | Allergic Rhinoconjunctivitis, Birch Pollen Allergy | 553 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05668390) |
| July 2, 2019 | NCT04004351 | Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma | Stallergenes Greer | Observational | Completed | Allergy | 1,531 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04004351) |
| May 14, 2015 | NCT02443805 | Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR | Stallergenes Greer | Phase 3 | Completed | Rhinitis, Allergic, Perennial, House Dust Mite Allergy | 1,607 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02443805) |
| November 20, 2014 | NCT02295969 | Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis | Stallergenes Greer | Observational | Completed | Allergy | 307 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02295969) |
| January 22, 2014 | NCT02041624 | International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis | Stallergenes Greer | Observational | Terminated | Allergic Rhinitis Due to Grass Pollens | 740 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02041624) |
| October 17, 2013 | NCT01964768 | Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing | Stallergenes Greer | Phase 3 | Completed | Allergy | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01964768) |
| August 29, 2013 | NCT01930461 | Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma | Stallergenes Greer | Phase 2 | Completed | Asthma, House Dust Mite Allergy | 386 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01930461) |
| August 9, 2013 | NCT01919554 | Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents | Stallergenes Greer | Phase 1 | Completed | Allergic Rhinitis Due to House Dust Mite | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01919554) |
| November 21, 2012 | NCT01731249 | Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis | Stallergenes Greer | Phase 3 | Completed | Hypersensitivity, Allergic Rhinitis, Allergic Conjunctivitis, Seasonal Allergy | 574 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01731249) |
| May 31, 2012 | NCT01608243 | Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts | Stallergenes Greer | Phase 1 | Completed | Asthma, House Dust Mite Allergy | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01608243) |
| February 6, 2012 | NCT01527188 | Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model | Stallergenes Greer | Phase 2 | Completed | Allergic Rhinitis Due to House Dust Mite | 355 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01527188) |
| October 20, 2010 | NCT01224834 | Safety and Tolerability Study of Ragweed SLIT Tablets | Stallergenes Greer | Phase 1 | Completed | Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01224834) |
| September 10, 2010 | NCT01199133 | Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children | Stallergenes Greer | Phase 3 | Terminated | Allergic Rhinitis Due to Dust Mite | 471 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01199133) |
| August 10, 2009 | NCT00955825 | Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen... | Stallergenes Greer | Phase 3 | Completed | Allergic Rhinitis Due to Grass Pollens | 473 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00955825) |
| May 14, 2009 | NCT00901914 | Study of rBet v1 Tablets | Stallergenes Greer | Phase 2 | Completed | Birch Pollen-related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal | 483 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00901914) |
| April 29, 2009 | NCT00889460 | Safety and Tolerability Study of rBet v1 SLIT Tablets | Stallergenes Greer | Phase 1 | Completed | Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00889460) |
| December 5, 2008 | NCT00803244 | Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis | Stallergenes Greer | Phase 3 | Completed | Primary Disease | 381 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00803244) |
| May 8, 2008 | NCT00674700 | Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis | Stallergenes Greer | Phase 2/3 | Completed | Allergic Rhinitis | 509 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00674700) |
| April 17, 2008 | NCT00660452 | A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to... | Stallergenes Greer | Phase 3 | Completed | Allergy | 484 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00660452) |
| February 21, 2008 | NCT00619827 | Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract | Stallergenes Greer | Phase 1 | Completed | Seasonal Allergic Rhinitis | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00619827) |
| January 4, 2007 | NCT00418379 | Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets | Stallergenes Greer | Phase 3 | Completed | Allergy | 633 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00418379) |
| December 13, 2006 | NCT00410930 | Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients | Stallergenes Greer | Phase 2 | Terminated | Allergy | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00410930) |
| December 8, 2006 | NCT00409409 | Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis | Stallergenes Greer | Phase 3 | Completed | Allergy | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00409409) |
| November 6, 2006 | NCT00396149 | Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1 | Stallergenes Greer | Phase 1 | Completed | Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00396149) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 2 | 4 |
| Phase 2/3 | 2 |
| Phase 3 | 10 |
| Observational | 4 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 23 |
| Terminated | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypersensitivity | 11 |
| Rhinitis, Allergic, Seasonal | 6 |
| Rhinitis, Allergic | 4 |
| Rhinitis | 3 |
| Conjunctivitis | 3 |
| Asthma | 3 |
| Dust Mite Allergy | 3 |
| Patient Compliance | 1 |
| Personal Satisfaction | 1 |
| Rhinitis, Allergic, Perennial | 1 |
| Conjunctivitis, Allergic | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Neurology practices in the United States](https://specstream.ai/data/businesses/neurology-practices/united-states)
- [Forestry services in the United States](https://specstream.ai/data/businesses/forestry-services/united-states)
- [Burmese restaurants in the United States](https://specstream.ai/data/businesses/burmese-restaurants/united-states)
- [Translation and interpreting companies in the United States](https://specstream.ai/data/businesses/translation-and-interpreting-companies/united-states)
- [Patio cover companies in the United States](https://specstream.ai/data/businesses/patio-cover-companies/united-states)
- [Hardware and fastener manufacturers in the United States](https://specstream.ai/data/businesses/hardware-and-fastener-manufacturers/united-states)
